TABLE OF CONTENTS
1 EXECUTIVE SUMMARY
1.1 OVERVIEW
2 MARKET INTRODUCTION
2.1 DEFINITION
2.2 SCOPE OF THE STUDY
2.3 RESEARCH OBJECTIVE
2.4 MARKET STRUCTURE
2.5 ASSUMPTIONS & LIMITATIONS
3 RESEARCH METHODOLOGY
3.1 DATA MINING
3.2 SECONDARY RESEARCH
3.3 PRIMARY RESEARCH
3.4 BREAKDOWN OF PRIMARY RESPONDENTS
3.5 FORECASTING TECHNIQUES
3.6 RESEARCH METHODOLOGY FOR MARKET SIZE ESTIMATION
3.6.1 BOTTOM-UP APPROACH
3.6.2 TOP-DOWN APPROACH
3.7 DATA TRIANGULATION
3.8 VALIDATION
4 MARKET DYNAMICS
4.1 OVERVIEW
4.2 DRIVERS
4.2.1 INCREASING INCIDENCE AND PREVALENCE OF KERATOCONUS DISORDERS
4.2.2 IMPROVING HEALTHCARE INFRASTRUCTURE
4.3 RESTRAINTS
4.3.1 LACK OF AWARENESS REGARDING KERATOCONUS DISORDERS
4.3.2 SIDE EFFECTS ASSOCIATED WITH TREATMENT
4.4 OPPORTUNITIES
4.4.1 INCREASING PRODUCT DEVELOPMENT AND LAUNCHES
5 MARKET FACTOR ANALYSIS
5.1 VALUE CHAIN ANALYSIS
5.1.1 R&D
5.1.2 MANUFACTURING
5.1.3 DISTRIBUTION & SALES
5.1.4 POST-SALES MONITORING
5.2 PORTER'S FIVE FORCES MODEL
5.2.1 THREAT OF NEW ENTRANTS
5.2.2 BARGAINING POWER OF SUPPLIERS
5.2.3 THREAT OF SUBSTITUTES
5.2.4 BARGAINING POWER OF BUYERS
5.2.5 INTENSITY OF RIVALRY
5.3 IMPACT OF COVID-19 ON THE CORNEAL CROSS-LINKING (CXL) DEVICES MARKET
5.3.1 IMPACT ON SUPPLY CHAIN
5.3.2 IMPACT ON PRODUCTION
5.3.3 IMPACT ON MARKET PLAYERS
5.4 REIMBURESEMENT SCENARIO FOR CXL PROCEDURES
6 GLOBAL RIBOFLAVIN SOLUTIONS MARKET SIZE AND STATISTICS
6.1 OVERVIEW
7 GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE
7.1 OVERVIEW
7.2 STANDARD CORNEAL CROSS LINKING
7.3 CORNEAL CROSS-LINKING PLUS
7.4 ACCELERATED CROSS-LINKING
8 GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD
8.1 OVERVIEW
8.2 EPITHELIUM-OFF METHOD
8.3 EPITHELIUM-ON METHOD
9 GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION
9.1 OVERVIEW
9.2 KERATOCONUS
9.3 PELLUCID MARGINAL DEGENERATION
9.4 REFRACTIVE SURGERY ECTASIA
9.5 OTHERS
10 GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER
10.1 OVERVIEW
10.2 HOSPITALS
10.3 EYE CLINICS
10.4 AMBULATORY SURGICAL CENTERS
11 GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY REGION
11.1 OVERVIEW
11.2 NORTH AMERICA
11.2.1 US
11.2.2 CANADA
11.3 EUROPE
11.3.1 GERMANY
11.3.2 UK
11.3.3 FRANCE
11.3.4 ITALY
11.3.5 SPAIN
11.3.6 REST OF EUROPE
11.4 ASIA-PACIFIC
11.4.1 JAPAN
11.4.2 CHINA
11.4.3 INDIA
11.4.4 AUSTRALIA
11.4.5 SOUTH KOREA
11.4.6 REST OF ASIA-PACIFIC
11.5 REST OF THE WORLD
11.5.1 MIDDLE EAST
11.5.2 AFRICA
11.5.3 LATIN AMERICA
12 COMPETITIVE LANDSCAPE
12.1 OVERVIEW
12.2 COMPETITIVE BENCHMARKING
12.3 GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET: COMPANY SHARE ANALYSIS
12.4 MAJOR GROWTH STRATEGY IN GLOBALCORNEAL CROSS-LINKING (CXL) DEVICES MARKET
12.5 THE LEADING PLAYER IN TERMS OF NUMBER OF DEVELOPMENTS IN GLOBAL CORNEAL CROSS-LINKING (CXL) DEVICES MARKET
12.6 KEY DEVELOPMENT ANALYSIS
12.7 KEY DEVELOPMENTS & GROWTH STRATEGIES
12.7.1 PARTNERSHIP/COLLABORATION
12.7.2 MERGERS & ACQUISITIONS
13 COMPANY PROFILE
13.1 GLAUKOS CORPORATION
13.1.1 COMPANY OVERVIEW
13.1.2 FINANCIAL OVERVIEW
13.1.3 PRODUCTS OFFERED
13.1.4 KEY DEVELOPMENTS
13.1.5 SWOT ANALYSIS
13.1.6 KEY STRATEGIES
13.2 EMAGINE AG
13.2.1 COMPANY OVERVIEW
13.2.2 FINANCIAL OVERVIEW
13.2.3 PRODUCTS OFFERED
13.2.4 KEY DEVELOPMENTS
13.2.5 SWOT ANALYSIS
13.2.6 KEY STRATEGIES
13.3 IVIS TECHNOLOGIES
13.3.1 COMPANY OVERVIEW
13.3.2 FINANCIAL OVERVIEW
13.3.3 PRODUCTS OFFERED
13.3.4 KEY DEVELOPMENTS
13.3.5 KEY STRATEGIES
13.4 IROMED GROUP SRL
13.4.1 COMPANY OVERVIEW
13.4.2 FINANCIAL OVERVIEW
13.4.3 PRODUCTS OFFERED
13.4.4 KEY DEVELOPMENTS
13.4.5 KEY STRATEGIES
13.5 PESCHKE GMBH
13.5.1 COMPANY OVERVIEW
13.5.2 FINANCIAL OVERVIEW
13.5.3 PRODUCTS OFFERED
13.5.4 KEY DEVELOPMENTS
13.5.5 SWOT ANALYSIS
13.5.6 KEY STRATEGIES
13.6 AJL OPHTHALMIC S.A.
13.6.1 COMPANY OVERVIEW
13.6.2 FINANCIAL OVERVIEW
13.6.3 PRODUCTS OFFERED
13.6.4 KEY DEVELOPMENTS
13.6.5 KEY STRATEGIES
14 APPENDIX
14.1 REFERENCES
14.2 RELATED REPORTS
LIST OF TABLES
TABLE 1 LIST OF ASSUMPTIONS & LIMITATIONS
TABLE 2 PRIMARY INTERVIEWS AND INFORMATION GATHERING PROCESS
TABLE 3 GLBOAL KERATOCONUS EPIDEMIOLOGY
TABLE 4 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR RIBOFLAVIN SOLUTIONS, BY REGION, 2018–2030 (USD MILLION)
TABLE 5 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 6 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR STANDARD CORNEAL CROSS-LINKING, BY REGION, 2018–2030 (USD MILLION)
TABLE 7 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR CORNEAL CROSS-LINKING PLUS, BY REGION, 2018–2030 (USD MILLION)
TABLE 8 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR ACCELERATED CROSS-LINKING, BY REGION, 2018–2030 (USD MILLION)
TABLE 9 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018–2030 (USD MILLION)
TABLE 10 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR EPITHELIUM-OFF METHOD, BY REGION, 2018–2030 (USD MILLION)
TABLE 11 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR EPITHELIUM-ON METHOD, BY REGION, 2018–2030 (USD MILLION)
TABLE 12 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018–2030 (USD MILLION)
TABLE 13 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR KERATOCONUS, BY REGION, 2018–2030 (USD MILLION)
TABLE 14 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR PELLUCID MARGINAL DEGENERATION, BY REGION, 2018–2030 (USD MILLION)
TABLE 15 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR REFRACTIVE SURGERY ECTASIA, BY REGION, 2018–2030 (USD MILLION)
TABLE 16 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR OTHERS, BY REGION, 2018–2030 (USD MILLION)
TABLE 17 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018–2030 (USD MILLION)
TABLE 18 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR HOSPITALS, BY REGION, 2018–2030 (USD MILLION)
TABLE 19 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR EYE CLINICS, BY REGION, 2018–2030 (USD MILLION)
TABLE 20 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, FOR AMBULATORY SURGICAL CENTERS, BY REGION, 2018–2030 (USD MILLION)
TABLE 21 GLOBAL: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY REGION, 2018–2030 (USD MILLION)
TABLE 22 NORTH AMERICA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 23 NORTH AMERICA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 24 NORTH AMERICA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018-2030 (USD MILLION)
TABLE 25 NORTH AMERICA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 26 NORTH AMERICA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 27 US: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 28 US: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018-2030 (USD MILLION)
TABLE 29 US: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 30 US: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 31 CANADA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 32 CANADA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018-2030 (USD MILLION)
TABLE 33 CANADA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 34 CANADA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 35 EUROPE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY COUNTRY, 2018–2030 (USD MILLION)
TABLE 36 EUROPE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 37 EUROPE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018-2030 (USD MILLION)
TABLE 38 EUROPE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 39 EUROPE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 40 GERMANY: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 41 GERMANY: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018-2030 (USD MILLION)
TABLE 42 GERMANY: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 43 GERMANY: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 44 UK: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 45 UK: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018-2030 (USD MILLION)
TABLE 46 UK: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 47 UK: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 48 FRANCE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 49 FRANCE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018-2030 (USD MILLION)
TABLE 50 FRANCE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 51 FRANCE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 52 ITALY: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 53 ITALY: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018-2030 (USD MILLION)
TABLE 54 ITALY: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 55 ITALY: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 56 SPAIN: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 57 SPAIN: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018-2030 (USD MILLION)
TABLE 58 SPAIN: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 59 SPAIN: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 60 REST OF EUROPE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018-2030 (USD MILLION)
TABLE 61 REST OF EUROPE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018-2030 (USD MILLION)
TABLE 62 REST OF EUROPE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018-2030 (USD MILLION)
TABLE 63 REST OF EUROPE: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018-2030 (USD MILLION)
TABLE 64 ASIA-PACIFIC: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY COUNTRY, 2018–2030 (USD MILLION)
TABLE 65 ASIA-PACIFIC: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 66 ASIA-PACIFIC: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018–2030 (USD MILLION)
TABLE 67 ASIA-PACIFIC: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018–2030 (USD MILLION)
TABLE 68 ASIA-PACIFIC: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018–2030 (USD MILLION)
TABLE 69 JAPAN: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 70 JAPAN: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018–2030 (USD MILLION)
TABLE 71 JAPAN: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018–2030 (USD MILLION)
TABLE 72 JAPAN: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018–2030 (USD MILLION)
TABLE 73 CHINA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 74 CHINA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018–2030 (USD MILLION)
TABLE 75 CHINA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018–2030 (USD MILLION)
TABLE 76 CHINA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018–2030 (USD MILLION)
TABLE 77 INDIA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 78 INDIA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018–2030 (USD MILLION)
TABLE 79 INDIA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018–2030 (USD MILLION)
TABLE 80 INDIA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY END USER, 2018–2030 (USD MILLION)
TABLE 81 AUSTRALIA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY TYPE, 2018–2030 (USD MILLION)
TABLE 82 AUSTRALIA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY METHOD, 2018–2030 (USD MILLION)
TABLE 83 AUSTRALIA: CORNEAL CROSS-LINKING (CXL) DEVICES MARKET, BY APPLICATION, 2018–2030 (USD MILLION)
